Chinese oncology startup Adagene closes $50M Series C led by Sequoia Capital
It’s been a busy week for biotech news coming out of China, and the latest financing round doesn’t break the trend. VC firm Sequoia Capital …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.